Not yet a member?Join now!|Lost password
Idenix Pharmaceuticals Inc.
Idenix Pharmaceuticals Inc.
11/26/2012 | Press release
Idenix Pharmaceuticals to Present at the 2012 Deutsche Bank Access BioFEST Conference
distributed by noodls on 11/26/2012 17:28
CAMBRIDGE, Mass., Nov. 26, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present in a fireside chat at the 2012 Deutsche Bank Access BioFEST Conference on December 3, 2012 at 4:00 p.m. ET at the Four Seasons Hotel in Boston.
The live and archived webcast of the company presentation can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection.http://www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)
Idenix Pharmaceuticals
